DocMorris posts Q3 2026 adjusted EBITDA of CHF 600,000
DocMorris reached adjusted EBITDA breakeven ahead of schedule in Q3 2026, posting CHF 600,000. September’s full repurchase of its CHF 49.6 million 2028 convertible bond was financed through a new convertible bond maturing in 2031. The 2026 adjusted EBITDA forecast improved to better than minus CHF 10 million, previousl